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Abstract.  Thrombin-induced expression of endothelial 
adhesivity toward neutrophils (PMN) was studied using 
human umbilical vein endothelial cells (HUVEC). 
HUVEC were challenged with human ot-thrombin for 
varying durations up to  120 min,  after which the cells 
were fixed with  1% paraformaldehyde and 5~Cr-labeled 
human  PMN were added to determine PMN adhesion. 
Endothelial  adhesivity increased within  15 min after 
c~-thrombin  exposure, and the response persisted up to 
120 min.  Expression of endothelial adhesion proteins, 
P-selectin (GMP-140, PADGEM, CD62), and intercel- 
lular adhesion molecule-1 (ICAM-1;  CD54) on the en- 
dothelial surface was quantitated by increase in the 
specific binding of anti-P-selectin mAb G1 and anti- 
ICAM-1 mAb RR1/1 labeled with 125I. P-selectin expres- 
sion was maximal  at 5-15 min o~-thrombin  exposure 
and decayed to basal levels within 90 min.  In con- 
trast,  ICAM-1 activity increased at 30 min and re- 
mained elevated for 120 min after o~-thrombin chal- 
lenge.  The initial endothelial adhesivity was dependent 
on P-selectin expression since PMN adhesion occur- 
ring within the first 30 min after ot-thrombin challenge 
was inhibited by mAb G1.  The later prolonged PMN 
adhesion was ICAM-1 dependent since this response 
was inhibited by mAb RR1/1 and to the same degree 
by the anti-CD18 mAb IB4. Anti-ELAM-1  rnAb BBll 
had no effect on adhesion of PMN to the a-thrombin- 
challenged cells. The initial P-selectin expression and 
PMN adhesion responses were reproduced by the 
14-amino peptide (SFLLRNPNDKYEPF) (thrombin- 
receptor activity peptide; TRP-14) which comprised 
the NH2 terminus created by thrombin's proteolytic ac- 
tion on its receptors.  However, TRP-14-induced PMN 
adhesion was transient,  and TRP-14 did not cause 
ICAM-1  expression.  The ICAM-l-dependent PMN ad- 
hesion mediated by ot-thrombin was protein synthesis 
independent since ICAM-1 expression and PMN adhe- 
sion were not inhibited by cycloheximide pretreatment 
of HUVEC. Moreover, Northern blot analysis indicated 
absence of ICAM-1  mRNA signal up to  180 min after 
ot-thrombin challenge. In conclusion, thrombin-induced 
endothelial adhesivity involves early- and late-phase 
responses. The initial  reversible PMN adhesion is me- 
diated by rapid P-selectin expression via TRP-14 gen- 
eration.  Thrombin-induced PMN adhesion is stabilized 
by a protein synthesis-independent upregulation of the 
constitutive ICAM-1 activity which enables the inter- 
action of ICAM-1  with the CD18 82 integrin on PMN. 
T  HROMBIN  causes  polymorphonuclear  leukocyte 
(PMN)'  adhesion to the endothelial  cell membrane 
by induction of endothelial  adhesivity (4, 12, 34, 38). 
We have shown that a slow intravenous  ot-thrombin infusion 
produces rapid PMN sequestration in pulmonary microves- 
sels secondary to attachment of PMN to vascular endothelial 
cells (8, 23, 24). Moreover, the PMN sequestration response 
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1. Abbreviations used in this paper: HUVEC, human umbilical'vein endo- 
thelial cells; ICAM-1, intercellular adhesion molecule; PATR, proteolyti- 
tally activated thrombin receptor, PMN, polymorphonuclear leukocytes; 
TNFc~, tumor necrosis factor c~; TRP, thrombin receptor activating peptide. 
typically persisted for several hours (8).  The resultant vas- 
cular injury and tissue inflammation  were critically  depen- 
dent on PMN sequestration in the microvessels (22). Studies 
showed that  ot-thromhin-induced  lung  vascular injury was 
prevented  by prior depletion of the circulating  PMN count 
(17, 20, 22, 24). 
The basis of increased endothelial adhesivity after ot-throm- 
bin challenge may involve expression of adhesive proteins on 
the  endothelial  plasma  membrane  (14,  26).  Thrombin  is 
known  to  rapidly  upregulate  P-selectin  (GMP-140,  PAD- 
GEM, CD62), a granular component of the Weibel-Palade 
body in endothelial  cells and azurophilic  granules of plate- 
lets (5, 13, 26). P-selectin is translocated to the endothelial 
cell plasma membrane where it rapidly induces PMN ad- 
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endothelial cell adhesion molecule, intercellular adhesion 
molecule-I (ICAM-1; CD54), may also be involved in medi- 
ating thrombin-induced PMN adhesion (12). ICAM-1 is ex- 
pressed in response to tumor necrosis factor alpha (TNF~) 
and interleukin 1 by a protein s3,nthesis--dependent  mechanism 
(30), but it remains unclear whether thrombin can exert a simi- 
lar effect on ICAM-1 induction. Previous studies have sug- 
gested that thrombin-induced expression of  endothelial adhe- 
sivity may be dependent on ICAM-1  (12). In this study we 
examined the time course of expression of endothelial adhe- 
sivity using human umbilical vein endothelial cells (-HUVEC). 
These cells were challenged with human o~-thrombin, and the 
relative contributions of P-selectin and ICAM-1 in mediating 
increased endothelial adhesivity were examined. The results 
indicate that the initial transient expression of thrombin- 
induced endothelial adhesivity is dependent on P-selectin, and 
that the adhesion response is prolonged and stabilized as the 
result of ICAM-1 expression. The induction of ICAM-1 ex- 
pression is a posttranslational event since it did not involve 
increased ICAM-1 mRNA signal and occurred in the pres- 
ence of cycloheximide. 
Materials and Methods 
Materials 
Ficoll-Paque was obtained from Pharmacia LKB Biotechnology  (Piscata- 
way, NJ). Chromium 51 (51C0 was obtained from New England Nuclear 
(Boston, MA). DME and HBSS were obtained from Gibco Laboratories 
(Grand Island, NY). Hepes, EDTA, gelatin (bovine skin type Ill), BSA, and 
cycloheximide  were obtained from Sigma Chemical Co. (St. Louis,  MO). 
FBS was obtained from Hyclone Laboratories Inc. (Logan, UT). TNFa was 
obtained from Cetus (EmeryviUe,  CA). Human ct-thrombin was prepared 
and evaluated as described (1I). Anti-CD18 mAb IB4 (37) and mAb OKM-1, 
a control mAb directed against an irrelevant isotope on CDllb (36, 37), 
were gifts from Dr. Samuel Wright, Rockefeller University, New' York. The 
anti-ICAM-1 mAb RR1/1 was a gift from Dr. Robert Rothlein, Boehringer- 
Ingelheim Pharmaceuticals,  Ridgefield, CT (30). The anti-endothelial leu- 
kocyte adhesion molecuie-1 mAb BBll (1) was a gift from Dr. Roy Lobb, 
Biogen Inc, Cambridge, MA. The anti-P-selectin mAb (31 and a control 
nonneutralizing anti-P-selectin  mAb S12 (13, 18, 25) were provided by Dr. 
Rodger  McEver, Department of Medicine, University of Oklahoma, OK 
(13, 18, 25). A control mAb W40 (18) was also provided by Dr. R. McEver. 
24- and 96-well  culture plates were obtained from Coming Class Inc. 
(Coming,  NY).  The  thrombin  receptor  activating  peptide  (TRP-14) 
SFLLRNPNDKYEPF was synthesized and confirmed by amino acid analy- 
sis and protein sequencing (3, 27, 3t, 33). The eDNA clone, CD1.8, for hu- 
man ICAM-1 was obtained from Dr. Timothy A. Springer, Harvard Medical 
School, Boston, MA. 
Isolation of  Neutrophiis 
Human PMN were isolated from blood of normal volunteers supplied  by 
the American Red Cross, Albany, NY. The blood was sedimented with the 
same volume of 4% dextran HBSS without Ca  2+ and Mg  2+ with 20 mM 
EDTA for 40 rain at room temperature.  After sedimentation, the leukocyte~ 
rich plasma layer was diluted in the same volume of HBSS with EDTA. The 
Ficoll-Paque (10 nil) layered with diluted leukocyte-rich  plasma was cen- 
trifuged for 30 rain at room temperature at 1,350 rpm (400 g). The pellet 
containing erythrocytes and PMN was resuspended, and after hypotonic ly- 
sis of  erythroqtte, PMN suspended in 1 mg/ml BSA, 20 mM EDTA, 25 mM 
HepeslHBSS were counted. 
Neutrophil Labeling 
The isolated PMN were labeled with 51Cr by incubating with 1/~Ci of 51Cr 
per 106 ceils in a 5% CO2 incubator at 37~  for 60 rain, washed three 
times with HBSS,  and resuspended in DME (2  x  107 cells/ml). 
Endothelial Cell Culture 
HUVEC were cultured as described (9). HUVEC at 17-24 passages were 
seeded onto gelatin-coated  24- or 96-well plates and grown to confluency. 
Adherence Assay 
Confluent HUVEC monolayers in 24-well plates were incubated (37~C; 5 % 
CO2;  98%  humidity) with c~-thrombin or TRP-14  for variot~s times in 
DME without serum. At the end of each incubation period, HUVEC were 
fixed with 1% paraformaidehyde/PBS  at room temperature for 15 rain, and 
then washed three times with DME without serum. The StCr-labeled  hu- 
man PMN (2 ￿  106 cells/ml DME) were distributed at 1 ml per well over 
the HUVEC and coincubated for 60 rain at 37~  in 5%  CO2 and 98% 
humidity.  A comparison was made using live HUVEC to determine the 
effects of fixation on the expression of endothelial adhesivity in response to 
a-thrombin. 
To  determine the  inhibitory effects  of  mAbs  on  PMN  adherence, 
HUVEC were treated with mAbs (G1, S12, RR1/1, or BBll) 15 min before 
51Cr-labeled PMN administration at a concentration of 10 #g/ml, or 51Cr- 
labeled PMN were treated with mAb IB4 or mAb OKM-1 30 rain before 
PMN-HUVEC  coincubation.  HUVEC  monolayers  were  then  gently 
washed three times with DME without serum to remove the nonadherent 
PMN. Endothelial monolayers  were kept overnight in 1 ml of 1 N NaOH 
at 4~  The cell lysates were scraped, collected in polypropylene  test tubes, 
and counted for radioactivity in a Tm Analytical Gamma Counter.  Phase 
contrast microscopy  confirmed HUVEC integrity  and PMN adherence to 
HUVEC. 
12~  i.la~led Antibody Binding Assay 
The time course of expression of endothelial adhesion molecules was deter- 
mined by the specific binding of 125I-labeled mAbs to HUVEC after ex- 
posure to a-thrombin or TRP-14 for varying durations.  The mAbs were io- 
dinated using the chloramine-T method. The specific activity of the labeled 
mAbs ranged from 3.7 to 6.6/~Ci/~g.  HUVEC grown to confluency in 96- 
well plates were washed with DME without serum and incubated  with either 
a-thrombin or TRP-14 for 5, 15, 30, 60, 90, or 120 rain. As a positive con- 
trol, HUVEC were incubated with TNFo~ (1,000 U/mt). At the end of the 
treatment periods, the cells were fixed with 1% paraformaldehyde/PBS  at 
room temperature for 15 rain and washed three times with DME with 10% 
FBS, and the t2SLlabeled mAb (10 #g/nil) was added with DME with 10% 
FBS (75 #1 per well) and allowed to incubate for 60 rain at 4oC. The cells 
were gently washed three times with DME with FBS to remove nonbinding 
t25I-labeled mAbs. The cells were kept overnight in 150 #1 of 1 N NaOH 
at 4~  after which the cell lysate was scraped, collected in test tubes, and 
counted for radioactivity in a Tm analytical gamma counter.  The specific 
binding of each mAb was determined by adding 30-fold excess unlabeled 
mAb. The binding  data were normalized to cell protein measured in control 
cells and after either a-thrombin or TRP-14 challenge. 
Northern Blot Analysis of  lCAM-1 Expression 
RNA was isolated according to the method described by Chomczynskl and 
Sacchi (7) with minor modifications.  After extraction with acid guanidine 
thiocyanate  phenol-chloroform, RNA was collected by precipitation with 
isopropanol.  The RNA pellet was dissolved  in TES buffer (10 mM Tris- 
HCI,  pH  7.5,  1 mM EDTA,  0.5%  SDS)  and extracted  once with PCI 
(phenol-chloroform-isoamyl  alcohol,  25:24:1)  and  once  with  chloro- 
formhsoamylalcohol (24:D.  The aqueous phase was collected by centrifu- 
gation at 10,000 rpm at 4oc, and then RNA was precipitated with 2 vol of 
ethanol in the presence of 0.2 M Na acetate.  After standing overnight at 
-20~  RNA was  collected by centrifugation and the RNA pellet was 
washed with 80% ethanol, dried, and dissolved in a small volume of diethyl 
pyrocarbamate-treated sterile distilled water. 
RNA was quantified by spcctrophotometry,  and equal amounts of RNA 
were subjected to electrophoresis on a denaturing agarose-formaldehyde  gel 
and  transferred to  nitrocellulose using the  standard  protocol.  Human 
ICAM-1 (0.96 kb Sall to psfl fragment) and glyceraldehyde-3-phosphate 
dehydrogenase (1.1-kb pstl fragment) were labeled with [a32p]dCTP using 
the random primer kit (obtained from 5 Prime to 3 Prime, Inc., Boulder, 
CO). Hybridization was carried out in the presence of 10% dextran and 
40% formamide for 16 h at 420C. The Northern blots were washed at 42~ 
twice with 2￿  SSC (0.15 M sodium c~orided0.015 M sodium citrate) con- 
taining 0.1% SDS at room temperature, and twice with 0.1  x  SSC containing 
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for developme,  t of autoradiogram. The blots were hybridized to ICAM-I, 
stripped, and rehybridized with glyceraldehyde-3-phosphate  dehydroge- 
nasa, a constitutively expressed gene. 
Data Analysis 
Statistical analysis was performed usin  8 the Student's t test and P < 0.05 
was considered to be significant. The results are shown as mean +  SEM. 
Results 
Thrombin Induces Rapid Endothelial Adhesiveness 
Fig. 1 shows the expression of  endothelial adhesiveness at 15 
and 120 min after thrombin challenge.  Studies were made 
using thrombin-challenged  HUVEC fixed with 1% parafor- 
maldehyde (see Materials and Methods). Endothelial  adhe- 
sivity increased in a concentration-dependent  manner within 
15 min after thrombin challenge,  and the hyperadhesive re- 
sponse was sustained up to  120 rain.  The increase in en- 
dothelial  adhesivity  after  ,-thrombin  (10  -s  M)  exposure 
was also evident in unfixed HUVEC;  i.e.,  wthrombin ex- 
posure followed by wash (three times) of HUVEC with DME 
increased PMN adhesion from a  basal value of 5.2  +  1.1% 
to 45.1  +  1.2% at 15 rain after c~-thrombin, and to 52.2  + 
3.5 %  at 120 rain after a-thrombin. 
Differential Expression of  P-Selectin and ICAM-I 
Expression of P-selectin assessed by the specific binding  of 
~25I-labeled mAb G1 to HUVEC peaked within 5 rain after 
thrombin challenge  (P < 0.05), remained at this value at 15 
rain, and decreased to near basal level by ,~90 rain (Fig. 2). 
In contrast, expression of ICAM4 (assessed by the specific 
binding of nSI-labeled anti-ICAM-mAb RR1/1)  increased at 
30 rain after thrombin challenge (P <  0.05)  and remained 
elevated at approximately maximum value up to the 120-rain 
study period (Fig. 2).  The challenge of paraformaldehyde- 
fixed HUVEC with o~-thrombin did not induce ICAM-1 ex- 
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Figure 1. Concentration-dependent etfects of a-thrombin on PMN 
adhesion.  The  effects  of two  concentrations of a-thrombin are 
shown.  HUVEC were treated with a-thrombin (10  -9 or 10  -8 M) 
for  15  or  120  rain,  fixed with  1%  paraformaldehyde/PBS, and 
washed, after which slCr-labeled PMN (2  ￿  10  ~ cells/ml) were 
layered onto endothelial cells for 1 h and adhesion was determined 
as described in Materials and Methods. Values are mean :i= SEM; 
n  :  8 for each condition. 
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Figure 2. Ttme course of  increase in specific binding of  1~I-RR1/1 
(anti-ICAM-1 mAb) and nSI-G1 (anti-P-selectin mAb) to HUVEC 
after a-thrombin (10  -8 M) exposure for 5,  15, 30, 60, 90, or 120 
min. After each treatment period, HUVEC were fixed and washed, 
and IzSI-labeled monoclonal antibodies were added for 1 h, after 
which specific  binding was determined by adding 30-fold excess un- 
labeled RR1/1 and G1. Birwlins data for nSI-RR1/1 and nSI-G1 were 
normalized to cell protein measured in control cells and after 
thrombin challenge (see Materials and Methods). Values are shown 
as mean  +  SEM; n  =  6 for each condition. 
challenged  with  a-thrombin,  which  were  then fixed.  The 
binding of control isotype matched IgG,  t2sI-labc|ed  rnAb 
W40, did not increase after thrombin challenge (i.e., control- 
specific  '~I binding was 30.6  +  1.9 ng/mg cell protein and 
values at 15, 30, and 120 min after thrombin were 24.2  + 
1.1, 23.0  +  3.1,  and 22.5  +  1.5, respectively). 
The expression of ICAM-1 was concentration dependent; 
l0 s M thrombin resulted in a greater expression than 10-9 M 
thrombin (Fig. 3). Since ,'~30 rain was required for the in- 
duction of ICAM-1 expression, we examined whether a short 
thrombin exposure period was sufficient to induce the re- 
sponse. HUVEC were treated with 10  -8 M thrombin for 1, 
5,  10, 30,  or  120 min,  washed three times,  and incubated 
with DME for 119, 115, 110, 90, or 0 rain, respectively, after 
which they were fixed (as in Materials and Methods),  and 
specific binding of ':SI-labeled  RR1/1 was determined (Fig. 
4). A period of thrombin exposure as short as 1 rain resulted 
in ICAM-1 expression (Fig. 4), indicating that thrombin rap- 
Table L Specific Binding of lZ~l-labeled Anti.ICAM-I 
mAb RR1/1 to Paraformaldehyde.frced HUVEC, Which 
Were Then Challenged with ~-Thrombin (IO s M) 
Specific  ~-RRI/I binding  to  HUVEC 
(rig/rag  total  cell  protein) 
30 rain  120 rain 
Basal  Control  a-Thrombin  Control  a-Thrombin 
47.5  57.3  63.1  58.0  46.1 
•  •  •  •  • 
Values are shown as mean  +  1 SEM (n ffi 6  for each condition). Values are 
.or ~;~y  ~t  from  each o~r. No~: ~ co,~,  ~  specific b~d- 
ing of  I-RR1/I  to 120 rain c~-thrombin-challenged  HUVEC that were then 
fixed with pamformaldehyde  was 244.1 +  14.2 rig/rag  total cell protein. 
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Figure 3. Concentration-dependent  effects of ,-thrombin on spe- 
cific  binding  of ~25I-labeled RR1/1 to  HUVEC.  HUVEC  were 
treated with c~-thrombin  (10  -9 and 10  -s M) for 15, 30, or 120 rain 
before fixation, after which 12SI-RR1/1 was added for 1 h and spe- 
cific binding was determined (see Materials and Methods). Values 
are shown as mean +  SEMi n  =  6 for each condition. 
idly activated the cellular signals responsible for ICAM-1 ac- 
tivation. 
Initial PMN Adhesion to Thrombin-activated 
Endothelial Cells Is P-Selectin Dependent and 
Prolonged Adhesion Is ICAM-1 Dependent 
Fig. 5 indicates that PMN adhesion occurring within the first 
30 rain ofthrombin exposure was P-selectin dependent, since 
the response was inhibited by treating thrombin-challenged 
endothelial  cells  with  mAb  G1.  A  nonneutralizing  anti- 
GMP-140 mAb S12 had no effect on this response (Table II). 
The sustained PMN adhesion response was inhibited by 
the anti-ICAM-1 mAb RR1/1 (Fig. 6), indicating the involve- 
ment of ICAM-1 in this phase of the response. The magni- 
tude and time course of inhibition with mAb RR1/1 were 
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Figure 4.  Effect of varying  periods  of cr  exposure  on 
ICAM-1 expression. HUVEC were treated for periods with 10  -8 M 
a-thrombin (i.e.,  1, 5, 10, 30, or 120 min), and ceils were washed 
three times and incubated with DME for 119, 115, 110, 90, or 0 
min, respectively, after which they were fixed and specific binding 
of 125I-RRV1 was determined (see Materials and Methods). Values 
are shown as mean +  SEMi n =  6 for each condition.  *Different 
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Figure 5. Effect of mAb G1 (anti-P-selectin) of thrombin-induced 
PMN adhesion to HUVEC. HUVEC were treated with mAb G1 (10 
/~g/ml) 15 rain before S~Cr-labeled PMN admim'stration (see Mate- 
rials and Methods).  PMN adhesion occurring  within the first 30 
min of thrombin challenge was P-seleetin dependent since the re- 
sponses at 15 and 30 min were inhibited by treatment of thrombin- 
challenged HUVEC with G1. Values are shown as mean +  SEMi 
n =  8 for each condition.  *Different from basal (0 time) PMN ad- 
hesion value (P <  0.05). 
similar to that observed with the mAb 1B4 directed against 
the CD18 82 integrin on PMN (Fig. 6), supporting the con- 
cept that ICAM-l-dependent PMN adhesion is mediated by 
binding of ICAM-1  on HUVEC to the CD18  integrin on 
PMN (12, 30). In contrast, control mAb OKM-1 against an 
irrelevant epitope on CD1 lb had no inhibitory effect on PMN 
adhesion to thrombin-challenged HUVEC (Table HI). The 
late-phase response was not affected by the anti-ELAM-1 
mAb BBll  (Fig.  7). 
We examined whether the delayed increase in ICAM-1 ac- 
tivity as a result of short-term thrombin incubation (shown 
in Fig. 4) could mediate ICAM-l-dependent adhesion to en- 
dothelial  ceUs.  In this  study,  HUVEC  were  treated  with 
10  -8 M thrombin for 15 min followed by a wash with DME 
and allowed to incubate in the DME for an additional  165 
min,  after  which  the  cells  were  fixed  (as  described  in 
Materials and Methods) and then treated with either mAb 
RR1/1 ormAb G1. MAb RR1/1 prevented the PMN adhesion, 
whereas mAb G1 was ineffective (Fig. 8), indicating that a 
short-term thrombin exposure (which induced ICAM-1 ex- 
pression [Fig. 4]) mediated PMN adhesion by an ICAM-1- 
dependent mechanism. 
Table IL Effect of  Anti-P-Selectin  mAb G1 on 
Thrombin-induced PMN Adhesion 
Percent PMN adhesion aRer c~-thrombin (at 15 rain) 
Basal  Control  mAb G1  mAb S12 
3.9  36.8*  4.4  38.7* 
+0.7  +3.6  +0.4  5=2.8 
HUVEC were challenged with 10  -8 M  (x-thrombin for 15 rain before parafor- 
maldehyde fixation. HUVEC were then treated with mAb G1  (10/~g/ml) or 
nonneutralizing  control  mAb  S12  (10  /~g/ml)  directed  against  P-selectin. 
Values are shown as mean  •  1 SEM (n  =  8  for each condition). 
* Different from basal and mAb GI  groups (P <  0.05). 
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Figure 6. Effect of mAb RR1/1 (anti-ICAM-1) and mAb 1:134 (anti- 
CD18)  on thrombin-induced  PMN adhesion  to HUVEC.  (/bp) 
HUVEC were treated with mAb RRI/1 (10/~g/ml)  15 rain before 
adding sICr-labeled PMN (see Materials and Methods) and (bot- 
tom) PMN were treated with mAb 1134 (10 #g/ml) 30 rain before 
PMN-HUVEC coincubation. The data indicate that the late-phase 
PMN adhesion was both ICAM-1 and CD18 dependent. Values are 
shown as mean + SEMi n =  8 for each condition. *Different from 
basal (0 time) (P < 0.05). *Different from control group values at 
corresponding  times (P < 0.05). 
TRP-14 Induces P-Selectin-dependent PMN Adhesion 
The synthetic peptide (SFLLRNPNDKYEPF), TRP-14, the 
U 
NH2-terminal  portion  of the  thrombin  receptor  activated  '~ 
by  ~-thrombin  (16, 35),  caused  the  rapid  expression  of  ~ 
P-selectin similar to that observed with o~-thrombin (Fig. 
9). A  120-rain period of treatment of HUVEC with TRP-14  [ 
Z 
Table IlL Effect of  Anti-CD18 mAb IB4 on 
Thrombin-induced  PMN Adhesion 
Percent  PMN adherence after a-thrombin (at  120 rain) 
Basal  Control  mAb IB4  mAb OKM-1 
2.1  30.0*  2.6  29.1" 
:t:0.1  +1.2  +0.04  +2.1" 
HUVEC were challenged with 10  -s M a~rombin for 120 rain before para- 
formaldehyde fixation. PMN were then treated  with mAb IB4 (10 ~g/ml) or 
OKM-I (10/tg/ml (a control  mAb directed  against an irrelevant  epitope on 
r 
Values are shown as mean +  1 SEM (n =  8 for each condition). 
* Different from basal and mAb I134 groups (P <  0.05). 
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Figure 7. Effect ofmAb BBll (anti-ELAM-1) on thrombin-induced 
PMN adhesion to HUVEC. HUVEC were treated with mAb BB11 
(10 pg/ml) 15 rain before addition of  PMN (see Materials and Meth- 
ods); the response was not affected by mAb BBll. Values are shown 
as mean +  SEMi n =  8 for each condition.  *Different from base- 
line (P <  0.05). 
or c~-thrombin did not increase the binding of 12~I-labeled 
mAb G1 (Fig. 9), indicating that the expression of P-selectin 
mediated by either thrombin or TRP-14 was a transient event. 
TRP-14 promoted PMN adhesion within  15 min and the 
response decreased with time, in contrast to the prolonged 
c~-thrombin-mediated PMN adhesion response (Table IV). 
The TRP-14-induced response was absent at 90 min, again 
in contrast to the thrombin response (Table IV). The TRP- 
14-mediated PMN response was P-selectin dependent, since 
it was inhibited by mAb G1 (Fig. 10), whereas adhesion was 
unaffected by mAb RR1/1 (anti-ICAM-1) or the control mAb 
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Figure 8. Short-terra thrombin exposure resulted in ICAM-l-depen- 
dent PMN adhesion. HUVEC were treated with a-thrombin (a-T; 
10  -s M) for 15 min, followed by wash with DME, and allowed to 
incubate in DME for an additional  165 rain, after which the cells 
were fixed and treated with either mAb RR1/1 or mAb (31 (see Ma- 
terials and Methods). PMN adhesion was prevented by mAb RRlh 
pretreatment  of HUVEC.  Values are shown as mean  +  SEMi 
n  -- 8 for each condition.  *Different from control  (P <  0.05). 
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Figure 9. The synthetic peptide (SFLLRNPNDKYEPF) (TRP-14) 
(i.e., the NH2-terminal portion of the thrombin receptor activated 
by ~-thrombin) caused rapid expression of P-selectin similar to that 
observed with c~-thrombin. HUVEC  were treated  with TRP-14 
(10  -4 M) or a-thrombin (10  -s M) for 15, 30, or 120 rain, fixed, 
and specific binding of t25I-G1 was quantified (see Materials and 
Methods). Values are shown as mean + SEM; n = 6 for each con- 
dition.  *Different from control (P < 0.05). 
PMN adhesion paralleled P-selectin expression (Figs. 9 and 
10). In contrast to the effect of ,-thrombin, TRP-14 did not 
mediate the expression of  ICAM-1 (Table VI), indicating that 
thrombin-induced  ICAM-1  activation  occurred  indepen- 
dently of TRP-14 generation from the proteolytically acti- 
vated thrombin receptor (PATR), 
TRP-I4 Pretreatment Prevents 
Thrombin-induced P-Selectin Expression and Delays 
the Increase in PMN Adhesion 
We examined the possibility that TRP-14 acted on the same 
receptor as ot-thrombin to induce the expression of  P-selectin. 
HUVEC were pretreated with either o~-thrombin  (10  -s M) 
or TRP-14 (10  -4 M) for 60 min, after which either TRP-14 
or tx-thrombin was added to the incubation medium for 30 
min. HUVEC were then fixed, and specific binding of ~I- 
labeled mAb (31 was determined. The results indicated that 
pretreatment of the cells with ot-thrombin or TRP-14 pre- 
vented the TRP-14- or c~-thrombin-induced binding of mAb 
Table IV.  Time Course of a-Thrombin-  and 
TRP-14-induced  Increases  in PMN Adhesion 
Percent PMN Adhesion 
Basal  15 min  30 min  90 min 
ct-Thrombin  4.4  45.3  47.8  39.4 
+0.3  •  •  • 
TRP-14  6.0  42.3  16.0"  6.2* 
•  1.2  •  1.7  •  • 
HUVEC were treated with .-thrombin (10  -s M) or TRP-14 (5  x  10  -s M) for 
15,  30,  or 90 rain and fixed with paraformaldehyde,  and S~Cr-labeled PMN 
were added to the monolayer to determine  PMN adhesion. 
Values are shown as mean  •  1 SEM (n =  8 for each condition). 
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Figure lO. The time course  oftbe TRP-14-induced increase  in endo- 
thelial adhesivity. TRP-14 induced PMN adhesion within 15 min 
after TRP challenge. HUVEC were treated with TRP-14 (10-4 M) 
for 15, 30, 45, 60, 90, or 120 rain before fixation (see  Materials and 
Methods). The response was P-selectin dependent since PMN adhe- 
sion was ini-dbited  by mAb (31. Values are shown as mean + SEM; 
n  =  8 for each condition. 
(anti-P-selectin) G1 that occurred typically within the 30- 
min period after TRP-14 or c~-thrombin challenge ~ig.  11). 
Therefore, a,-thrombin or TRP-14 pretreatment of HUVEC 
desensitized endothelial cells to subsequent stimulation with 
TRP-14 or c~-thrombin,  indicating that P-selectin upregula- 
tion was mediated by action of TRP-14 and c~-thrombin  on 
the same receptor site. 
Pretreatment  of  HUVEC  with  TRP-14  delayed  the 
,-thromhin-induced PMN adhesion; i.e., the adhesion re- 
sponse was not evident within 15 min after c~-thrombin chal- 
lenge, as was the case in control HUVEC that had not been 
exposed  to  TRP-14  (Fig.  12).  Only  the  delayed ICAM- 
dependent PMN adhesion response was observed (Fig. 12). 
This  delayed thrombin-induced  PMN  adhesion  response 
observed after TRP-I4 pretreatment was  associated  with 
ICAM-1 expression, and the PMN adhesion was inhibited by 
mAb RR1/1 (Table VID. These findings indicate that TRP-14 
pretreatment desensitized the HUVEC to the initial P-selec- 
tin-mediated increase in adhesion, but not the subsequent 
prolonged ICAM-l-mediated PMN adhesion response. 
Thrombin-induced ICAM-I Expression Occurs by a 
Protein Synthesis-independent Mechanism 
Treatment of endothelial cells with 6 #g/ml cycloheximide 
Table V. Effect of  Anti-P-Selectin mAb G1 
and Anti-ICAM-1  mAb RR1/1 on TRP-I4-induced 
PMN Adhesion 
Percent  PMN adhesion after TRP-14 
(at  15 rain) 
Basal  Control  mAb G1  mAb RRI/I  mAb S12 
6.1  39.5*  7.1  41.2*  38.2* 
+0.2  +2.8  +0.8  +3.3  +4.5 
HUVEC were treated with 5  ￿  10  -5 M TRP-14 for 15 rain before parafor- 
maldehyde  fixation.  HUVEC  were treated  with G1  (10/~g/ml), RR1/I  (10 
/~g/ml), or S12  (10/~g/ml)  (a control  nonneutralizing  mAb directed  against 
P-selectm). 
Values are shown as mean  5:1  SEM (n  =  8 for each condition). 
* Different from basal and mAb GI groups (P <  0.05). 
The Journal of Cell Biology, Volume  119, 1992  940 Table VL Specific Binding of J25I-labeled 
Anti-ICAM-1 mAb RRI/1 after TRP-14 (5 x  10  -5 M) 
Treatment of  HUVEC  for 120 Min 
12SI-RR/1 binding al~r TRP-14 
(at 120 min) 
Basal  TRP-I 
lz~I-RRl/1 binding  45.0  +  4.2  25.4  +  0.7 
(ng/ml cell protein) 
Values are shown as mean + 1 SEM (n = 6 for each group). 
failed to  alter the  binding  of ~z~I-labeled mAb RRF1  in- 
duced by ct-thrombin (Fig.  13).  Moreover, cycloheximide 
did not prevent PMN adhesion to the ct-thrombin-challenged 
endothelial cells (Fig.  13).  TNF= treatment of endothelial 
cells  for  120 min induced  ICAM-1  expression as well as 
PMN adhesion, and cycloheximide prevented both ICAM-1 
expression and PMN adhesion (Fig. 13). ICAM-1 upregula- 
tion induced by a-thrombin was not the result of increased 
transcription of the ICAM-1  message since Northern blot 
analysis did not show an increase in the ICAM-1 mRNA sig- 
nal up to 180 min after ct-thrombin challenge, whereas in a 
positive control  experiment,  TNF~  challenge  of HUVEC 
resulted in an increase in ICAM-1 mRNA within 120 min of 
TNF~ exposure (Fig.  14). 
Discussion 
Thrombin-induced PMN sequestration in the microvascula- 
ture (23, 24) may largely be the result of expression of en- 
dothelial  adhesivity  (4,  12,  34,  38).  Studies  using  Hqn- 
oxine-labeled PMN indicated that PMN sequestration in the 
pulmonary microvasculature occurred rapidly after throm- 
1200  ￿9 
1000, 
800. 
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Figure 11. Effect of pretreatment with c~-thrombin  (a-T) or TRP-14 
on TRP-14- or ~-thrombin-induced  specific binding of 125I-G1 (anti- 
P-selectin mAb). HUVEC were pretreated with either ct-thrombin 
(10  -8 M) or TRP-14 (10  -4 M) for 60 min, after which either TRP- 
14 or c~-thrombin  was added to the incubation medium for 30 min. 
HUVEC were then fixed and the specific binding of ~I-G1 was 
determined.  The results  also show the effects of t~-thrombin or 
TRP-14 alone, as well as the effects of  TRP-14 and c~-thrombin  with- 
out the initial treatment with TRP-14 or r  The findings 
indicate that t~-thrombin or TRP-14 pretreatment prevented the sub- 
sequent expression of P-selecfin after the second challenge with ei- 
ther TRP-14 or t~-thrombin. Values are shown as mean +  SEM; 
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Figure 12. Effect of TRP-14 pretreatment  on ct-thrombin-induced 
PMN adherence to HUVEC.  In the TRP-14 pretreatment  group, 
HUVEC  were  pretreated  with  TRP-14 (10  -4  M)  for  60  rain. 
a-Thrombin (10  -8 M) was then added to the incubation medium 
for 15, 30, 60, and 90 min. After fixation, PMN adherence was de- 
termined (see Materials  and Methods).  The results indicate that 
TRP-14 pretreatment significantly reduced the early (i.e., at 15 and 
30 min) PMN adhesion mediated by t~-thrombin. Values are shown 
as mean + SEM; n = 4 for each condition. *Different from control 
group values at corresponding  times (P <  0.05). 
bin exposure (10  -8 M), and the response persisted for up to 
120-180 min (8). The PMN-endothelial interaction may be 
a  critical determinant of vascular endothelial  injury  since 
thrombin-induced pulmonary microvascular endothelial in- 
jury was prevented after depletion of the circulating PMN 
count (17, 20). However, the basis ofthrombin-induced PMN 
sequestration  in microvessels remains unclear despite the 
evidence of the involvement of PMN in the pathogenesis of 
endothelial injury. Previous studies have shown that throm- 
bin promotes PMN adherence to cultured endothelial cells 
by expression of endothelial adhesiveness (14, 26). This re- 
sponse may involve rapid upregulation of P-selectin (5,  13, 
26),  which  is released from Weibel-Paiade bodies in en- 
dothelial ceils within 15 min after ot-thrombin challenge (14, 
15, 26). The translocation of P-selectin to the plasmalemmal 
membrane may contribute to PMN adhesion to endothelial 
cells, and thus may be responsible for the rapid intravascular 
sequestration of PMN (23, 24). However, the transient nature 
of the P-selectin-dependent response does not explain the 
persistence of PMN sequestration observed in experimental 
models of acute lung injury after intravenous cr  in- 
fusion (8). 
In this  study we examined the relative contributions  of 
P-selectin and another critical adhesion molecule, ICAM-1, 
in  sustaining  PMN  adhesion  to c~-thrombin-activated en- 
dothelial cells. The results indicated a rapid expression of  en- 
dothelial adhesivity occurring within 15 min after ot-thrombin 
challenge,  and this was followed by stabilization of PMN 
adhesion.  The initial response was dependent on the rapid 
upregulation of P-selectin as evident by increase in the spe- 
cific binding of ~I-labeled anti-P-selectin mAb G1  within 
15 min after thrombin challenge, and then decrease to basal 
levels within 60--90 min. The time course of P-selectin ex- 
pression is consistent with the data of McEver et al.  (26) 
showing  that  ~-thrombin  can  rapidly  mobilize P-selectin 
from its endothelial cell stores. The delayed and more sus- 
Sugama et al. Endothelial Adhesivity Mediated by Thrombin  941 Table VII. Effect of TRP-14 Pretreatment on Thrombin-induced  Expression of  lCAM-1 
125I-RR1/1 binding  Percent adherence 
(ng/mg cell protein)  Percent PMN adherence  +  RRI/1 
Basal  43.7  :t:  5.1  3.4  +  2.9 
TRP-14  (5  x  10  -5  M)  276.1  +  22.5*  29.8  +  2.9* 
Pretreatment  for 
30 min/c~-Thrombin 
(9O min) 
5.5  +  0.3 
HUVEC were pretreated with TRP-14 (5  x  10  -5 M) for 30 rain, at which point 10  -s M  c~-thrombin  was added to the incubation for a 90-rain period. The cells 
were then fixed with paraformaldehyde and binding of lz~I-labeled RRI/1  and ICAM-1 dependence of PMN adhesion response were determined. 
Values are shown as mean +  1 SEM  (n  =  6  for each condition in binding assay and n  =  8  for each condition in adherence assay). 
* Different from basal values (P <  0.05). 
tained PMN adhesion after thrombin challenge was ICAM-1 
dependent.  ICAM-1  expression  increased  at  30  min  after 
thrombin  challenge  (i.e.,  after  maximum  expression  of 
P-selectin had occurred),  and persisted for up to  120 min. 
This phase of PMN adhesion was ICAM-1 dependent since 
it was inhibited by the ICAM-1 mAb RR1/1; however, the re- 
sponse was unaffected by the anti-ELAM-1 mAb BBll. These 
results cannot be explained by the release of secondary medi- 
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Figure 13. Effect of cycloheximide on thrombin-induced  ICAM-1 
expression. HUVEC were pretreated with cycloheximide (6 t~g/ml) 
(which we showed to inhibit protein  synthesis based on [3H]leu- 
cine incorporation)  30 min before c~-thrombin (10  -s M) or TNF, 
(1,000 U/ml) challenge. (Top)  Treatment of HUVEC with cyclohex- 
imide failed to alter the binding of ~25I-RR1/I induced by cx-throm- 
bin challenge. (Bottom)  Treatment of HUVEC with cycloheximide 
also  failed  to alter the  PMN  adhesion  to  HUVEC  induced  by 
a-thrombin challenge.  In contrast,  both specific binding  of ~25I- 
RR1/1 and PMN adherence  induced by TNF~ were significantly 
reduced by cycloheximide pretreatment. Values are shown as mean 
+  SEM; n  =  6 (binding assay) and n  =  8 (adherence assay) for 
each condition. 
ators from endothelial cells (12)  since the cells were fixed 
with  1%  paraformaldehyde after challenge with thrombin. 
The present results are consistent with the hypothesis that the 
initial  attachment of PMN to  ot-thrombin-activated endo- 
thelial  cells  is  mediated by P-selectin,  and  the prolonged 
adhesion response (a characteristic feature of PMN seques- 
tration in the microcirculation [8]) is dependent on ICAM-1 
upregulation. 
Induction of ICAM-1 by the cytokines (ILA~ and TNF~) 
as well as by lipopolysaccharide requires  de novo protein 
synthesis  secondary  to  the  transcription  of the  ICAM-1 
mRNA (10).  In this  study,  ICAM-1  activation induced  by 
o~-thrombin  occurred  by  a  protein  synthesis-independent 
mechanism  since  neither  ICAM-1  expression  nor  PMN 
adhesion to thrombin-challenged endothelial  ceils was af- 
fected by cycloheximide pretreatment. Moreover, there was 
no  evidence  of increased  ICAM-1  transcription;  that  is, 
ICAM-1  mRNA  signal  was  not  altered  within  the  2-3-h 
Figure 14. Northern  blot analysis of ICAM-1 mRNA signal after 
c~-thrombin  challenge up to 180 rain. TNFa challenge (1,000 U/ml) 
of HUVEC resulted in an increase of ICAM-1 mRNA within 120 
min after TNFc~ exposure,  whereas thrombin treatment  (10  -s M) 
was ineffective. GAPDH,  glyceraldehyde-3-phosphate  dehydrog- 
enase. 
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Figure  15.  The  schematic of a-thrombin-induced 
endothelial adhesiveness, c~-Thrombin  activates the 
PATR, which has the 14 amino acid new NH2-ter- 
minal sequence of SFLLRNPNDKYEPF.  TRP-14 
induces P-selectin expression on the luminal surface 
of endothelial ceils. ICAM-1 expression occurring 
by a protein synthesis-independent mechanism may 
be explained by activation of the constitutive cell 
surface ICAM-1 by thrombin's proteolytic activity 
or release of cell stores of ICAM-1 by binding of 
(~-thrombin  to another membrane receptor. Another 
possibility is that (~-thrombin induces a conforma- 
tional change of PATR, and thereby signals ICAM-1 
activation without the involvement of TRP-14. The 
P-selectin expression is important in early PMN ad- 
hesion to endothelial cells, whereas ICAM-1 expres- 
sion prolongs and  stabilizes the  PMN  adherence 
response. 
period after ot-thrombin challenge. In contrast, TNF~ chal- 
lenge of endothelial cells for 120 min resulted in the typical 
increase in ICAM-1  mRNA activity as well as ICAM-1  pro- 
tein expression. 
The action of o(-thrombin in mediating ICAM-1 activation 
may be specific to thrombin since we have shown that an- 
other serine protease, plasmin, does not increase endothelial 
adhesiveness (19). One explanation of thrombin's effect may 
be a qualitative increase in the activity of the constitutive 
ICAM-1 on the endothelial cell membrane. A  similar phe- 
nomenon occurring with CD18 expression on PMN involves 
clustering of CD18/92  integrin,  and is associated with in- 
creased amounts of the membrane surface antigen (21, 29). 
Thrombin-induced ICAM-1 expression does not involve gen- 
eration of the thrombin receptor activating peptide (SFL- 
LRNPNDKYEPF) (TRP-14) since we showed that the NH2 
terminus peptide generated from the thrombin receptor (35) 
(which simulates thrombin's effects such as platelet aggrega- 
tion [16]) failed to promote ICAM-1  expression. This pep- 
tide,  however,  resulted  in  rapid  and  reversible P-selectin 
expression as well as P-selectin-dependent PMN adhesion, 
consistent  with  our  previous  observations  (32),  suggest- 
ing that the signal for P-selectin activation (in contrast to 
ICAM-1  activation) requires the PATR. 
We observed that pretreatment of HUVEC  with  either 
ot-thrombin or TRP-14 prevented P-selectin expression in 
response to a  subsequent challenge with either TRP-14 or 
ot-thrombin. This evidence of cross-desensitization supports 
the conclusion that P-selectin upregulation was mediated by 
activation of PATR (13, 16, 35). The results are in agreement 
with reports of desensitization of intracellular calcium mo- 
bilization by TRP-14 or c~-thrombin  (6). 
Although  the  desensitization  of PATR  by  TRP-14 pre- 
vented the rapid initial P-selectin-induced PMN adhesion, it 
did not modify the prolonged ICAM-l-dependent PMN ad- 
hesion,  indicating that ICAM-l-dependent PMN adhesion 
was mediated independently of TRP-14. While the induction 
of P-selectin only requires the presence of TRP-14, ICAM-1 
expression may involve activation of another as yet undefined 
thrombin receptor or direct t~-thrombin-mediated activation 
of  ICAM-1 secondary to a conformational change induced by 
proteolysis (Fig.  15).  It is also possible that a  proteolyti- 
cally induced conformational change of PATR could signal 
ICAM-1  expression without the involvement of TRP-14. 
The dual regulation of thrombin-induced endothelial ad- 
hesiveness by both P-selectin- and ICAM-l-dependent mech- 
anisms may be an important process in the development of 
vascular injury and tissue inflammation. The prolonged intra- 
vascular PMN  sequestration seen in experimental models 
of  vascular injury after t~-thrombin challenge (8) may be crit- 
ically dependent on ICAM-1  expression, and thereby may 
amplify  the  injury  by  stabilizing  PMN  adhesion  to  en- 
dothelial cells.  It remains to be determined whether anti- 
ICAM-1 antibodies prevent the thrombin-induced neutrophil 
sequestration in microvessels in situ,  and also prevent the 
vascular injury and inflammation attributed to PMN seques- 
tration (8). 
Since anti-ELAM-1 mAb BBll failed to inhibit adhesion 
Sugama et al. Endothelial Adhesivity Mediated by Thrombin  943 to thrombin-activated endothelial cells, this study excludes 
the  involvement  of ELAM4  in  mediation  of thrombin- 
induced adhesiveness.  This is in contrast to the described 
effects of IL-I~, TNF~, and lipopolysaccharide  in inducing 
ELAM-l-dependent adhesion to endothelial cells (2). More- 
over, the ELAM-l-dependent adhesion required induction of 
ELAM-1 mRNA and de novo protein synthesis (28), which 
is in contrast to the protein synthesis-independent  effect of 
ot-thrombin in mediating ICAM-1 expression. 
In conclusion, we have shown that ~-thrombin induces the 
expression of endothelial adhesiveness, leading to prolonged 
PMN adhesion to endothelial cells. The initial PMN adhe- 
sion to c~-thrombin-activated  endothelial cells is mediated by 
P-selecfin, and the adhesion response is prolonged by ICAM- 
I activation. P-selectin expression is rapid and is terminated 
within 60-90 rain, which is the time when ICAM-1 activity 
peaks.  P-selectin  expression  is the result of activation of 
PArR and the generation of TRP-14, and is independent of 
ICAM-1 activation (Fig.  15). ICAM-1 expression  does not 
involve induction of ICAM-1 mRNA, and is probably a post- 
translational event since ICAM-1 activity and PMN adhesion 
are unaffected by cycloheximide pretreatment. The increase 
in ICAM-1 activity may involve proteolytic  modification of 
the surface-bound ICAM-1 or release of preformed ICAM-1 
by activation of another thrombin receptor  (Fig.  15).  An- 
other possibility  is that proteolytically  induced conforma- 
tional change of PATR signals ICAM-1 expression.  Expres- 
sion of endothelial  ICAM-1 may  serve  to stabilize  PMN 
adhesion  to thrombin-activated endothelial  cells,  and thus 
may prolong intravascular PMN sequestration. 
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